Cargando…

Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria

Background: Lecithin cholesterol acyltransferase (LCAT) is an important enzyme in cholesterol metabolism that is involved in the esterification of cholesterol. A lack of this enzyme results in deranged metabolic pathways that are not completely understood, resulting in abnormal deposition of lipids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Althaf, Mohammed Mahdi, Almana, Hadeel, Abdelfadiel, Ahmed, Amer, Sadiq Mohammed, Al-Hussain, Turki Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Diabetic Nephropathy Prevention 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316582/ https://www.ncbi.nlm.nih.gov/pubmed/25657982 http://dx.doi.org/10.12860/jnp.2015.05

Ejemplares similares

Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency
por: Fistrek Prlic, Margareta, et al.
Publicado: (2022)

Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia
por: Conca, Paola, et al.
Publicado: (2012)

Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
por: Baragetti, Andrea, et al.
Publicado: (2020)

Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations
por: Katayama, Akihiro, et al.
Publicado: (2011)

Corneal thickness in the case of familial lecithin-cholesterol acyltransferase deficiency
por: Kinoshita, Shinsuke, et al.
Publicado: (2021)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
por: Ossoli, Alice, et al.
Publicado: (2016)

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency
por: Vitali, Cecilia, et al.
Publicado: (2022)

Familial lecithin-cholesterol acyltransferase deficiency: If so rare, why so frequent in the state of Piauí, northeastern Brazil?
por: de Serpa Brandão, Rafael Melo Santos, et al.
Publicado: (2022)

Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase
por: Glukhova, Alisa, et al.
Publicado: (2015)

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol
por: Manthei, Kelly A, et al.
Publicado: (2018)

Hypolipidemic effect and activation of Lecithin Cholesterol Acyl Transferase (LCAT) by aqueous extract of Spirulina platensis during toxicological investigation
por: Ama Moor, Vicky Jocelyne, et al.
Publicado: (2017)

LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes
por: Kuroda, Masayuki, et al.
Publicado: (2022)

Lecithin: Cholesterol Acyltransferase and Na(+)-K(+)-ATPase Activity in Patients with Breast Cancer
por: Özmen, Hilal Kiziltunç, et al.
Publicado: (2013)

Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles
por: Manthei, Kelly A., et al.
Publicado: (2020)

Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency
por: Lamiquiz-Moneo, Itziar, et al.
Publicado: (2019)

Current Status of Familial LCAT Deficiency in Japan
por: Kuroda, Masayuki, et al.
Publicado: (2021)

Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides
por: Casteleijn, Marco G., et al.
Publicado: (2018)

First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency
por: Aso, Masayuki, et al.
Publicado: (2022)

Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin–Cholesterol Acyltransferase Autoantibody
por: Komatsu, Tomohiro, et al.
Publicado: (2023)

Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia
por: Tobar, Hugo E., et al.
Publicado: (2019)

Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism
por: Gunawardane, Ruwanthi N., et al.
Publicado: (2016)

The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency
por: Pavanello, Chiara, et al.
Publicado: (2021)

Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice
por: Manzini, S., et al.
Publicado: (2015)

Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
por: Norum, Kaare R., et al.
Publicado: (2020)

Plasma Lecithin-Cholesterol Acyltransferase Activity in Pregnant Women Enrolled in the iLiNS-DYAD Trial in Ghana
por: Hong, Brian, et al.
Publicado: (2022)

Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis
por: Gao, Hongliang, et al.
Publicado: (2022)

Corrigendum: Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis
por: Gao, Hongliang, et al.
Publicado: (2023)

Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids
por: Giorgi, Laura, et al.
Publicado: (2022)

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
por: George, Richard T., et al.
Publicado: (2021)

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency
por: Savel, Julia, et al.
Publicado: (2012)

Association of Lecithin Cholesterol Acyltransferase rs5923 Polymorphism in Iranian Individuals with Extremely Low High-Density Lipoprotein Cholesterol: Tehran Lipid and Glucose Study
por: Naseri, Mohsen, et al.
Publicado: (2015)

Lipoprotein X Causes Renal Disease in LCAT Deficiency
por: Ossoli, Alice, et al.
Publicado: (2016)

Co-existence of classic familial lecithin-cholesterol acyl transferase deficiency and fish eye disease in the same family
por: Mahapatra, H. S., et al.
Publicado: (2015)

Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study
por: Yokoyama, Katsuaki, et al.
Publicado: (2018)

Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile
por: Niemelä, Akseli, et al.
Publicado: (2021)

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea
por: Flores, Rhonda, et al.
Publicado: (2019)

Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans
por: Pavanello, Chiara, et al.
Publicado: (2022)

LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred
por: Mehta, Roopa, et al.
Publicado: (2021)

An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level
por: Balwani, Manish R, et al.
Publicado: (2016)

Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency
por: Gomaraschi, Monica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7hd9cqabkdt5vk2ihsa7op6i8